Abstract
The process of somatic cell reprogramming is gaining increasing interest as reprogrammed cells are considered to hold a great therapeutic potential. However, with current technologies this process is relatively inefficient. Recent studies reported that inhibition of the p53 tumor suppressor profoundly facilitates reprogramming and attributed this effect to the ability of p53 to restrict proliferation and induce apoptosis. Given that mesenchymal-to-epithelial transition (MET) was recently shown to be necessary for reprogramming of fibroblasts, we investigated whether p53 counteracts reprogramming by affecting MET. We found that p53 restricts MET during the early phases of reprogramming and that this effect is primarily mediated by the ability of p53 to inhibit Klf4-dependent activation of epithelial genes. Moreover, transcriptome analysis revealed a large transcriptional signature enriched with epithelial genes, which is markedly induced by Klf4 exclusively in p53−/− cells. We also found that the expression of the epithelial marker E-Cadherin negatively correlates with p53 activity in a variety of mesenchymal cells even before the expression of reprogramming factors. Finally, we demonstrate that the inhibitory effect of p53 on MET is mediated by p21. We conclude that inhibition of the p53–p21 axis predisposes mesenchymal cells to the acquisition of epithelial characteristics and renders them more prone to reprogramming. Our study uncovers a novel mechanism by which p53 restrains reprogramming and highlights the role of p53 in regulating cell plasticity.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- ESC:
-
embryonic stem cells
- MEF:
-
mouse embryonic fibroblasts
- QRT-PCR:
-
quantitative real-time PCR
- MET:
-
mesenchymal-to-epithelial transition
- EMT:
-
epithelial-to-mesenchymal transition
- TGFβ:
-
transforming growth factor β
- iPSC:
-
induced pluripotent stem cells
- Klf4:
-
Krüppel-like factor 4
- shRNA:
-
small hairpin RNA
References
Vousden KH, Prives C . Blinded by the light: the growing complexity of p53. Cell 2009; 137: 413–431.
Brosh R, Rotter V . Transcriptional control of the proliferation cluster by the tumor suppressor p53. Mol Biosyst 2010; 6: 17–29.
Molchadsky A, Rivlin N, Brosh R, Rotter V, Sarig R . p53 is balancing development, differentiation and de-differentiation to assure cancer prevention. Carcinogenesis 2010; 31: 1501–1508.
Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA, Butel JS et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992; 356: 215–221.
Armstrong JF, Kaufman MH, Harrison DJ, Clarke AR . High-frequency developmental abnormalities in p53-deficient mice. Curr Biol 1995; 5: 931–936.
Sah VP, Attardi LD, Mulligan GJ, Williams BO, Bronson RT, Jacks T . A subset of p53-deficient embryos exhibit exencephaly. Nat Genet 1995; 10: 175–180.
Hu W . The role of p53 gene family in reproduction. Cold Spring Harb Perspect Biol 2009; 1: a001073.
Takahashi K, Yamanaka S . Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663–676.
Utikal J, Polo JM, Stadtfeld M, Maherali N, Kulalert W, Walsh RM et al. Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature 2009; 460: 1145–1148.
Marión RM, Strati K, Li H, Murga M, Blanco R, Ortega S et al. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 2009; 460: 1149–1153.
Li H, Collado M, Villasante A, Strati K, Ortega S, Cañamero M et al. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 2009; 480: 1136–1139.
Kawamura T, Suzuki J, Wang YV, Menendez S, Morera LB, Raya A et al. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 2009; 480: 1140–1144.
Hong H, Takahashi K, Ichisaka T, Aoi T, Kanagawa O, Nakagawa M et al. Suppression of induced pluripotent stem cell generation by the p53–p21 pathway. Nature 2009; 460: 1132–1135.
Hanna J, Saha K, Pando B, van Zon J, Lengner CJ, Creyghton MP et al. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 2009; 462: 595–601.
Sarig R, Rivlin N, Brosh R, Bornstein C, Kamer I, Ezra O et al. Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells. J Exp Med 2010; 207: 2127–2140.
Samavarchi-Tehrani P, Golipour A, David L, Sung HK, Beyer TA, Datti A et al. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell 2010; 7: 64–77.
Li R, Liang J, Ni S, Zhou T, Qing X, Li H et al. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell 2010; 7: 51–63.
Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, Gonzalez F et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 2008; 26: 1276–1284.
Thiery JP, Sleeman JP . Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006; 7: 131–142.
Chaffer CL, Thompson EW, Williams ED . Mesenchymal to epithelial transition in development and disease. Cells Tissues Organs 2007; 185: 7–19.
Polyak K, Weinberg RA . Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 2009; 9: 265–273.
Evans PM, Liu C . Roles of Krupel-like factor 4 in normal homeostasis, cancer and stem cells. Acta Biochim Biophys Sin (Shanghai) 2008; 40: 554–564.
Rowland BD, Bernards R . Peeper DS. The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat Cell Biol 2005; 7: 1074–1082.
Yori JL, Johnson E, Zhou G, Jain MK, Keri RA . Kruppel-like factor 4 inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expression. J Biol Chem 2010; 285: 16854–16863.
van Roy F, Berx G . The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci 2008; 65: 3756–3788.
Chen T, Yuan D, Wei B, Jiang J, Kang J, Ling K et al. E-cadherin-mediated cell-cell contact is critical for induced pluripotent stem cell generation. Stem Cells 2010; 28: 1315–1325.
Soncin F, Mohamet L, Eckardt D, Ritson S, Eastham AM, Bobola N et al. Abrogation of E-cadherin-mediated cell-cell contact in mouse embryonic stem cells results in reversible LIF-independent self-renewal. Stem Cells 2009; 27: 2069–2080.
Pinho AV, Rooman I, Real FX . p53-dependent regulation of growth, epithelial-mesenchymal transition and stemness in normal pancreatic epithelial cells. Cell Cycle 2011; 10: 1312–1321.
Rinon A, Molchadsky A, Nathan E, Yovel G, Rotter V, Sarig R et al. p53 coordinates cranial neural crest cell growth and epithelial-mesenchymal transition/delamination processes. Development 2011; 138: 1827–1838.
Rowland BD, Peeper DS . KLF4, p21 and context-dependent opposing forces in cancer. Nat Rev Cancer 2006; 6: 11–23.
Zhang W, Geiman DE, Shields JM, Dang DT, Mahatan CS, Kaestner KH et al. The gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter. J Biol Chem 2000; 275: 18391–18398.
Chen X, Xu H, Yuan P, Fang F, Huss M, Vega VB et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 2008; 133: 1106–1117.
Brosh R, Shalgi R, Liran A, Landan G, Korotayev K, Nguyen GH et al. p53-repressed miRNAs are involved with E2F in a feed-forward loop promoting proliferation. Mol Syst Biol 2008; 4: 229.
Cheng JC, Auersperg N, Leung PCK . Inhibition of p53 represses E-cadherin expression by increasing DNA methyltransferase-1 and promoter methylation in serous borderline ovarian tumor cells. Oncogene 2011; 30: 3930–3942.
Cordenonsi M, Dupont S, Maretto S, Insinga A, Imbriano C, Piccolo S . Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with Smads. Cell 2003; 113: 301–314.
Mizuno H, Spike BT, Wahl GM, Levine AJ . Inactivation of p53 in breast cancers correlates with stem cell transcriptional signatures. Proc Natl Acad Sci USA 2010; 107: 22745–22750.
Solomon H, Brosh R, Buganim Y, Rotter V . Inactivation of the p53 tumor suppressor gene and activation of the Ras oncogene: cooperative events in tumorigenesis. Discov Med 2010; 9: 448–454.
Foster KW, Liu Z, Nail CD, Li X, Fitzgerald TJ, Bailey SK et al. Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia. Oncogene 2005; 24: 1491–1500.
Sharan R, Maron-Katz A, Shamir R . CLICK and EXPANDER: a system for clustering and visualizing gene expression data. Bioinformatics 2003; 19: 1787–1799.
Huang da W, Sherman BT, Lempicki RA . Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4: 44–57.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Edited by G Melino
Supplementary Information accompanies the paper on Cell Death and Differentiation website
Rights and permissions
About this article
Cite this article
Brosh, R., Assia-Alroy, Y., Molchadsky, A. et al. p53 Counteracts reprogramming by inhibiting mesenchymal-to-epithelial transition. Cell Death Differ 20, 312–320 (2013). https://doi.org/10.1038/cdd.2012.125
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/cdd.2012.125
Keywords
This article is cited by
-
Time-resolved Small-RNA Sequencing Identifies MicroRNAs Critical for Formation of Embryonic Stem Cells from the Inner Cell Mass of Mouse Embryos
Stem Cell Reviews and Reports (2023)
-
Differential mechanisms underlying methotrexate-induced cell death and epithelial-mesenchymal transition in A549 cells
Toxicological Research (2021)
-
p73 is required for appropriate BMP-induced mesenchymal-to-epithelial transition during somatic cell reprogramming
Cell Death & Disease (2017)
-
Reprogramming barriers and enhancers: strategies to enhance the efficiency and kinetics of induced pluripotency
Cell Regeneration (2015)
-
Mitofusins deficiency elicits mitochondrial metabolic reprogramming to pluripotency
Cell Death & Differentiation (2015)
